SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-026637
Filing Date
2018-10-12
Accepted
2018-10-12 16:11:13
Documents
1
Period of Report
2018-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1495
  Complete submission text file 0000899243-18-026637.txt   2854
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 307 WESTLAKE AVE. NORTH, STE 300 SEATTLE WA 98109
Business Address
Azelby Robert (Reporting) CIK: 0001656998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35347 | Film No.: 181120359